• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8344493).
  

PubMed=6243721; DOI=10.1093/jnci/64.3.465
Ian Trevor Magrath, Philip A. Pizzo, Jacqueline Whang-Peng, Edwin C. Douglass, Oliver Alabaster, Paul Gerber, Charles Bryan Freeman, Ligita Novikovs;
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I Physical, cytogenetic, and growth characteristics.
J. Natl. Cancer Inst. 64:465-476(1980)

PubMed=6243722; DOI=10.1093/jnci/64.3.477
Ian Trevor Magrath, Charles Bryan Freeman, Philip A. Pizzo, James Gadek, Elaine Sarkin Jaffe, Maria Santaella, Carl Hammer, Michael M. Frank, Gregory Reaman, Ligita Novikovs;
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen II. Surface markers.
J. Natl. Cancer Inst. 64:477-483(1980)

PubMed=6265077
Philip A. Pizzo, Sisir K. Chattopadhyay, Ian Trevor Magrath, Eric Del Giacco, D.W. Sherrick, Thomas E. Gray;
Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Cancer Res. 41:3165-3171(1981)

PubMed=8344493; DOI=10.1096/fasebj.7.10.8344493
Kishor G. Bhatia, Walter Goldschmidts, Marina I. Gutierrez, Gianluca Gaidano, Riccardo Dalla-Favera, Ian Trevor Magrath;
Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
FASEB J. 7:951-956(1993)

PubMed=8515068; DOI=10.4049/jimmunol.150.12.5418
Vinay K. Jain, Jean-Gabriel Judde, Edward E. Max, Ian Trevor Magrath;
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
J. Immunol. 150:5418-5428(1993)